Eloxx Pharmaceuticals, Inc. Cash Flow Reinvestment Rate
Latest as of March 2025:
0.00x
Eloxx Pharmaceuticals, Inc. cash flow reinvestment rate. Eloxx Pharmaceuticals, Inc. (ELOX) has a Cash Flow Reinvestment Rate of 0.00x as of March 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.20 Million. See financial agility of Eloxx Pharmaceuticals, Inc. to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$1.20 Million
USD
Capital Expenditures
$0.00
USD
Eloxx Pharmaceuticals, Inc. Cash Flow Reinvestment Rate by Year (None–None)
Eloxx Pharmaceuticals, Inc. cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Eloxx Pharmaceuticals, Inc.. For the full cash flow conversion analysis, see Eloxx Pharmaceuticals, Inc. (ELOX) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow